儿童喘和COVID-19疫苗接种:揭示犹和接受的模式
Marzieh Tavakol1, Saber Gharagozlou2, Mohammad Abbasi3
1Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Therapeutic advances in vaccines and immunotherapy
|November 15, 2024
概括
伊朗喘儿童中,COVID-19疫苗的犹是普遍存在的,受到家庭和父母决定的影响. 解决安全问题和错误信息对于改善这一弱势群体的疫苗接种率至关重要.
科学领域:
- 儿科过敏和免疫学
- 传染病流行病学 传染病流行病学
- 公共卫生 公共卫生
背景情况:
- 由于COVID-19的流行,需要快速开发和部署疫苗.
- 对于疫苗的犹仍然是全球疾病控制的重大障碍.
- 喘儿童代表了一个关于接种疫苗接受的独特考虑的子组.
研究的目的:
- 调查COVID-19疫苗的犹和接受,特别是在伊朗的喘儿童中.
- 确定影响这一群体疫苗接种决策的人口和家庭因素.
- 了解喘儿童接受疫苗和犹的主要驱动因素.
主要方法:
- 在伊朗的一个过敏诊所进行了一项横截面研究.
- 共有522名5至18岁的喘儿童参与了这项研究.
- 数据是通过人口统计,疫苗接种情况和影响因素的问卷收集的.
主要成果:
- 只有27.5%的喘儿童接种了COVID-19疫苗.
- 父母的疫苗接种情况,孩子的年龄和父母的COVID-19病史与疫苗接种率有关.
- 接种疫苗的关键动机是安全性和COVID-19的严重程度;犹源于副作用的担忧和缺乏信心.
结论:
- 伊朗喘儿童的COVID-19疫苗接种率较低,父母的决定发挥着重要作用.
- 需要有针对性的干预措施来解决犹因素,如安全问题和错误信息.
- 医疗保健提供者在促进疫苗接受和打击这一群体内的错误信息方面至关重要.
相关概念视频
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
Asthma: Pathogenesis and Management
359
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
359
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K


